Interacoustics VisualEyes VNG Update Expands Diagnostic Capabilities
The VisualEyes VNG update features new, data-driven assessments to help clinicians understand how patients function in daily activities.
The VisualEyes VNG update features new, data-driven assessments to help clinicians understand how patients function in daily activities.
HCPs can expand their impact by increasing awareness of the diverse causes of hearing loss and by actively connecting with both current and potential patients through community outreach and professional partnerships.
Knowing the auditory, vestibular, and cognitive issues associated with chronic illnesses can help hearing care professionals better treat patients with these conditions.
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
Researchers have identified and mapped diverse cell types in the cochlear nucleus, a critical part of the auditory system, advancing understanding of how our brains process sounds and paving the way for targeted treatments for auditory disorders.
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.
As a partner with the NBA and WNBA Minnesota basketball teams, Starkey will provide hearing protection for all home games.
ICS Dizcovery VNG offers all-in-one, plug-and-play goggles that work with a unified diagnostic software platform for comprehensive vestibular assessment.
Henry Schein is donating essential healthcare products to be used for athlete health screenings at the 2025 Special Olympics World Winter Games in Turin, Italy.